Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IDF1
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0005488 | binding | 1 | 12 |
GO:0008270 | zinc ion binding | 6 | 9 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
GO:0046914 | transition metal ion binding | 5 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 274 | 278 | PF00656 | 0.548 |
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.389 |
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.318 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.441 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.403 |
CLV_NRD_NRD_1 | 247 | 249 | PF00675 | 0.500 |
CLV_PCSK_FUR_1 | 243 | 247 | PF00082 | 0.522 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.441 |
CLV_PCSK_KEX2_1 | 213 | 215 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.470 |
CLV_PCSK_KEX2_1 | 245 | 247 | PF00082 | 0.404 |
CLV_PCSK_PC1ET2_1 | 232 | 234 | PF00082 | 0.516 |
CLV_PCSK_PC1ET2_1 | 245 | 247 | PF00082 | 0.384 |
CLV_PCSK_PC7_1 | 243 | 249 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.336 |
CLV_PCSK_SKI1_1 | 163 | 167 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.358 |
CLV_PCSK_SKI1_1 | 329 | 333 | PF00082 | 0.261 |
CLV_Separin_Metazoa | 293 | 297 | PF03568 | 0.677 |
DOC_MAPK_gen_1 | 116 | 123 | PF00069 | 0.457 |
DOC_PP4_FxxP_1 | 322 | 325 | PF00568 | 0.511 |
DOC_USP7_UBL2_3 | 168 | 172 | PF12436 | 0.440 |
DOC_USP7_UBL2_3 | 328 | 332 | PF12436 | 0.451 |
DOC_USP7_UBL2_3 | 345 | 349 | PF12436 | 0.461 |
LIG_14-3-3_CanoR_1 | 17 | 22 | PF00244 | 0.308 |
LIG_14-3-3_CanoR_1 | 202 | 208 | PF00244 | 0.457 |
LIG_deltaCOP1_diTrp_1 | 145 | 152 | PF00928 | 0.502 |
LIG_FHA_2 | 164 | 170 | PF00498 | 0.438 |
LIG_FHA_2 | 18 | 24 | PF00498 | 0.387 |
LIG_LIR_Apic_2 | 320 | 325 | PF02991 | 0.419 |
LIG_LIR_Gen_1 | 143 | 153 | PF02991 | 0.409 |
LIG_LIR_Gen_1 | 20 | 28 | PF02991 | 0.387 |
LIG_LIR_Gen_1 | 305 | 315 | PF02991 | 0.602 |
LIG_LIR_Nem_3 | 108 | 114 | PF02991 | 0.384 |
LIG_LIR_Nem_3 | 143 | 149 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 161 | 165 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 20 | 24 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 305 | 311 | PF02991 | 0.611 |
LIG_Pex14_1 | 167 | 171 | PF04695 | 0.435 |
LIG_Pex14_2 | 152 | 156 | PF04695 | 0.349 |
LIG_SH2_CRK | 115 | 119 | PF00017 | 0.365 |
LIG_SH2_CRK | 58 | 62 | PF00017 | 0.302 |
LIG_SH2_SRC | 21 | 24 | PF00017 | 0.423 |
LIG_SH2_STAP1 | 129 | 133 | PF00017 | 0.432 |
LIG_SH2_STAP1 | 180 | 184 | PF00017 | 0.562 |
LIG_SH2_STAT3 | 41 | 44 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.409 |
LIG_SUMO_SIM_par_1 | 11 | 16 | PF11976 | 0.359 |
LIG_TRAF2_1 | 263 | 266 | PF00917 | 0.500 |
LIG_UBA3_1 | 280 | 287 | PF00899 | 0.570 |
LIG_WRC_WIRS_1 | 162 | 167 | PF05994 | 0.436 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.363 |
MOD_CK2_1 | 17 | 23 | PF00069 | 0.337 |
MOD_CK2_1 | 276 | 282 | PF00069 | 0.593 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.478 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.489 |
MOD_GlcNHglycan | 371 | 374 | PF01048 | 0.748 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.395 |
MOD_GSK3_1 | 368 | 375 | PF00069 | 0.695 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.415 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.620 |
MOD_PKA_1 | 17 | 23 | PF00069 | 0.302 |
MOD_PKA_1 | 29 | 35 | PF00069 | 0.302 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.441 |
MOD_PKA_2 | 288 | 294 | PF00069 | 0.587 |
MOD_Plk_2-3 | 124 | 130 | PF00069 | 0.443 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.577 |
MOD_Plk_4 | 317 | 323 | PF00069 | 0.605 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.370 |
MOD_SUMO_for_1 | 196 | 199 | PF00179 | 0.443 |
MOD_SUMO_for_1 | 218 | 221 | PF00179 | 0.513 |
MOD_SUMO_for_1 | 231 | 234 | PF00179 | 0.459 |
MOD_SUMO_for_1 | 331 | 334 | PF00179 | 0.387 |
MOD_SUMO_rev_2 | 11 | 20 | PF00179 | 0.302 |
MOD_SUMO_rev_2 | 169 | 173 | PF00179 | 0.423 |
TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.530 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 9 | 12 | PF00928 | 0.303 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.398 |
TRG_ER_diArg_1 | 182 | 184 | PF00400 | 0.457 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.415 |
TRG_ER_diArg_1 | 246 | 248 | PF00400 | 0.492 |
TRG_NLS_Bipartite_1 | 17 | 33 | PF00514 | 0.423 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE61 | Leptomonas seymouri | 86% | 100% |
A0A0S4J1C8 | Bodo saltans | 53% | 81% |
A0A1X0NZG6 | Trypanosomatidae | 63% | 100% |
A0A422P4I6 | Trypanosoma rangeli | 60% | 100% |
A4HEC3 | Leishmania braziliensis | 92% | 100% |
A4I1R8 | Leishmania infantum | 99% | 100% |
C9ZKC5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
E9AXV3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
E9Q8D0 | Mus musculus | 41% | 71% |
O14213 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 99% |
Q0II91 | Bos taurus | 39% | 71% |
Q4Q9L8 | Leishmania major | 96% | 100% |
Q5F1R6 | Homo sapiens | 40% | 71% |
Q6PGY5 | Danio rerio | 38% | 69% |
V5ASJ0 | Trypanosoma cruzi | 58% | 100% |